EGFR and neoplasm: The transcription factor, STAT5a/b, which is immediately downstream of EGFR Y845, also showed a significant decrease in phosphorylation at tyrosine positions 694 and 699 in both adjacent normal (P = 0.004) and tumor (P = 0.01) tissue samples from Anthos-treated animals.